As a scientist at argenx, Bram Van Den Eeckhout experiences the power of collaboration firsthand. In his role, he and his colleagues work alongside expert academic partners to develop new potential treatment candidates for autoimmune diseases. Partnerships with leaders in disease biology are made possible through our Immunology Innovation Program (IIP). Discover more about the program and our partners: https://bit.ly/4bH0EKL #TogetherWeDiscover
Your Future Fridays: Bram Van Den Eeckhout
Collaboration is key in advancing treatments for autoimmune diseases! Exciting to see how argenx's Immunology Innovation Program fosters partnerships to drive innovation.
Love this
Exciting times!
This is great, plenty of groups specialize in certain disorders and other topics, collaborations are a way to foster advancements 👍